Title of article :
Effects of N-acetylcysteine on outcomes in chronic obstructive pulmonary disease (Bronchitis Randomized on NAC Cost-Utility Study, BRONCUS): a randomised placebo-controlled trial
Author/Authors :
Marc Decramer، نويسنده , , Maureen Rutten-van Molken، نويسنده , , PN Richard Dekhuijzen، نويسنده , , Thierry Troosters، نويسنده , , Cees van Herwaarden، نويسنده , , Riccardo Pellegrino، نويسنده , , CP Onno van Schayck، نويسنده , , Dario Olivieri، نويسنده , , Mario Del Donno، نويسنده , , Wilfried De Backer، نويسنده , , Ida Lankhorst، نويسنده , , Alfredo Ardia، نويسنده ,
Issue Information :
روزنامه با شماره پیاپی سال 2005
Pages :
9
From page :
1552
To page :
1560
Abstract :
Background Increased oxidative stress is important in the pathogenesis of chronic obstructive pulmonary disease (COPD). We postulated that treatment with the antioxidant N-acetylcysteine would reduce the rate of lung-function decline, reduce yearly exacer
Journal title :
The Lancet
Serial Year :
2005
Journal title :
The Lancet
Record number :
588037
Link To Document :
بازگشت